Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 April 2021 | Story Eugene Seegers | Photo Supplied
Adelia Chauque graduates with distinction despite hindrances
Adelia Chauque graduated with distinction during the April Virtual Graduations hosted by the UFS.

On 20 April 2021, 693 South Campus students graduated during a virtual ceremony, with 213 of them achieving distinctions. One of these is Adelia Chauque, the newly elected South Campus SRC member for Policy and Transformation. During her journey as a student, Adelia says that she had numerous obstacles to overcome. For instance, she mentions that her “biggest challenge was completing my tasks with an unstable data connection during the pandemic”. Despite this impediment, Adelia managed to excel in her studies and obtained her qualification with distinction.

Adelia says her family was her biggest support system. “Due to the network problems that I faced my family had to drive me around until we found a stable connection that enabled me to write my tests.” Other support came from the university itself. “I received a lot of support from the academic adviser, Mr Chwaro Shuping,” she says. “Although he couldn't arrange for me to return to campus, he called regularly to ensure that I was still academically active.” 

After overcoming these hurdles, Adelia is continuing her academic journey. “I am enthusiastic and eager to learn or to better myself. Due to that, I am furthering my studies by enrolling for a second degree programme in Administration majoring in Industrial Psychology. I am very ambitious, in the sense that I strive for perfection and consistency with an organised and maintainable future, therefore being part of the SRC enables me to assist students and myself with a secured and comfortable learning environment to achieve our goals at the institution.” 

Adelia balances her responsibilities in the SRC portfolio of Policy and Transformation on the South Campus by having a schedule planned that ensures she does not fall behind. She concludes, “During the morning, I attend my prescribed lectures to ensure that I will continue to slay academically. Then I am visible in the SRC office from 12:00 to 16:30. After hours, I contribute my time to study, but I remain available to students who prefer texting.” The university is keen to see the heights to which Adelia will attain in the coming years.

 

“I am enthusiastic and eager
to learn or to better myself.”
Adelia Chauque, South Campus SRC:
Policy and Transformation.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept